Page 381 - ESHRE2019

COMPANY SYMPOSIA - MOZART
Monday, 24 June 2019:
11:45
11:45 11:50
11:57 12:17 12:37 12:57
14:00
14:00 14:05
14:25 14:45 15:05
17:00
- 13:00
Company Symposium Merck
Redefining success: the future
Chair: Georg Griesinger (Germany)
Welcome: Merck commitment to innovation
Thomas D’Hooghe (Belgium)
Introduction: From making babies to allowing everyone, who wishes to, to have babies (“dynamic” management of patients)
Georg Griesinger (Germany)
Outcomes that matter
Sesh Kamal Sunkara (United Kingdom)
LH for outcomes
Peter Humaidan (Denmark)
Bringing Lab Outcomes to Life
Matthew VerMilyea (U.S.A.)
Conclusions
Georg Griesinger (Germany)
Company Symposium IBSA
The ways ahead in reproductive care
Chair: Anna Veiga (Spain) Chair: Mona Aboulghar (Egypt)
Welcome and introduction
The role of progesterone in feto-maternal immunological cross talk
Julia Szekeres-Bartho (Hungary)
Mitochondria for oocytes: endogenous or exogenous sources
Elena Labarta Demur (Spain)
Beyond euploidy: what is next in embryo assessment
Laura Francesca Rienzi (Italy)
Discussion and conclusion
Company Symposium Gedeon Richter
An update on cryopreservation: Indications, contraindications and current perspectives
Chair: Kazem Nouri (Austria)
Elective Indications and contraindications for Freeze All
Christophe Blockeel (Belgium)
Non-Elective Indications, cost and safety for Freeze All
Juan Garcia Velasco (Spain)
Cryopreservation: an investment in the future?
Kirsten Louise Tryde Macklon (Denmark)
Closing Remarks
Kazem Nouri (Austria)
- 15:15
- 18:15
COMPANY SYMPOSIA I VIENNA, AUSTRIA – 23 TO 26 JUNE 2019
381
COMPANY SYMPOSIA